1,100.33
-24.13 (-2.15%)
| Previous Close | 1,124.46 |
| Open | 1,116.66 |
| Volume | 82,367 |
| Avg. Volume (3M) | 160,608 |
| Market Cap | 22,279,936,000 |
| Price / Earnings (TTM) | 25.82 |
| Price / Earnings (Forward) | 28.49 |
| Price / Sales | 6.81 |
| Price / Book | 1.33 |
| 52 Weeks Range | |
| Earnings Date | 30 Jul 2026 |
| Profit Margin | 22.17% |
| Operating Margin (TTM) | 25.19% |
| Diluted EPS (TTM) | 40.10 |
| Quarterly Revenue Growth (YOY) | -4.60% |
| Quarterly Earnings Growth (YOY) | -7.80% |
| Current Ratio (MRQ) | 1.01 |
| Operating Cash Flow (TTM) | 972.81 M |
| Levered Free Cash Flow (TTM) | 743.66 M |
| Return on Assets (TTM) | 21.22% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Diagnostics & Research (US) | Mixed | Bullish |
| Diagnostics & Research (Global) | Mixed | Bullish | |
| Stock | Mettler-Toledo International, I | Bearish | Bullish |
AIStockmoo Score
| Analyst Consensus | -2.0 |
| Insider Activity | NA |
| Price Volatility | 4.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.13 |
|
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%. |
|
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Investment Style | Mid Core |
| % Held by Insiders | 0.42% |
| % Held by Institutions | 101.90% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |